Although ADT with enzalutamide treatment initially increased the infiltration of CD4 + helper cells, it sensitized PCa cells to CD8 + T cell killing by downregulating the expression of antiapoptotic gene NAIP (neuronal apoptosis inhibitory protein) (Ardiani et al., 2014). The gene discussed is NAIP; the disease is posterior cortical atrophy.